Alpha 2.0
Login Register
» Authors » S Panagiotou

S Panagiotou

Explore the profile of S Panagiotou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 96
Followers 0
Related Specialties
Cell Biology
Biochemistry
General Medicine
Top 10 Co-Authors
P M Martin
A Hatzoglou
E Castanas
E Bakogeorgou
M Kampa
S Loukas
A Kyziridou
F Calvo
T Toliou
P A Patinakis
Published In
J Cell Biochem
J Hum Nutr Diet
Cytopathology
Adv Exp Med Biol
Affiliations
Soon will be listed here.
Recent Articles
1.
The economic burden of gluten-free products and gluten-free diet: a cost estimation analysis in Greece
Panagiotou S, Kontogianni M
J Hum Nutr Diet . 2017 May; 30(6):746-752. PMID: 28480510
Background: Adherence to a gluten-free diet (GFD) demonsrates various difficulties, including the high cost of the diet. The present study aimed to (i) compare the cost of gluten-free products (GFP)...
2.
Somatostatin and opioid receptors in mammary tissue. Role in cancer cell growth
Hatzoglou A, Bakogeorgou E, Kampa M, Panagiotou S, Martin P, Loukas S, et al.
Adv Exp Med Biol . 2000 Aug; 480:55-63. PMID: 10959409
Somatostatin and opioid systems, are the two main inhibitory systems in mammals. Both classes of substances have been identified in normal and malignant mammary gland, as well as their cognitive...
3.
Potent inhibitory action of red wine polyphenols on human breast cancer cells
Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, et al.
J Cell Biochem . 2000 Jun; 78(3):429-41. PMID: 10861841
Breast cancer (one of the most common malignancy in Western societies), as well as esophagus, stomach, lung, bladder, and prostate cancer, depend on environmental factors and diet for growth and...
4.
Cytological findings of abdominal malignant leiomyoblastoma (epithelioid leiomyosarcoma) in ascitic fluid; a case report
Patinakis P, Vlachou M, Kyziridou A, Platanias C, Panagiotou S, Toliou T, et al.
Cytopathology . 1999 Dec; 10(5):345-8. PMID: 10588354
No abstract available.
5.
Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements
Panagiotou S, Bakogeorgou E, Papakonstanti E, Hatzoglou A, Wallet F, Dussert C, et al.
J Cell Biochem . 1999 May; 73(2):204-11. PMID: 10227383
Opioids decrease cell proliferation in different systems including breast, prostate, lung, kidney, and intestine, through an interaction with opioid as well as other membrane-receptor systems (somatostatin, cholinergic), through an unidentified...
6.
Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems
Panagiotou S, Hatzoglou A, Calvo F, Martin P, Castanas E
J Cell Biochem . 1998 Nov; 71(3):416-28. PMID: 9831078
In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or...